EN
HI
Summary
As of 11 Nov, 2026, Remus Pharmaceuticals stock price is ₹820.5. During the trading session, the stock has moved between an intraday low of ₹814.50 and an intraday high of ₹825.00. Over the last 52 weeks, Remus Pharmaceuticals has traded between ₹580.00 and ₹1039.00.
The stock has recorded a trading volume of 2,800 shares,. Its Average Traded Price (ATP) is ₹818.66, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 500 @ ₹820.50.
Remus Pharmaceuticals has an upper circuit limit of ₹984.60 and a lower circuit limit of ₹656.40. The total value traded stands at ₹22.92 L, and the delivery percentage for the day is 85.71%.
The stock is currently traded with a market lot size of 100. Remus Pharmaceuticals also offers a dividend yield of 0.12%.
Remus Pharmaceuticals Share Price Chart
Remus Pharmaceuticals Share Key Metrics
Volume
2800.00
Market Cap
966.88 CR
LTQ@LTP
500@820.50
ATP
818.66
Var Margin
53.5 %
Circuit Range
656.4-984.6
Delivery %
85.71 %
Value
22.92 L
ASM/GSM
No
Market Lot
100
Remus Pharmaceuticals Fundamentals
P/E Ratio
26.14
P/B Ratio
2.75
Div. Yield
0.12
Sector P/E
61.48
Sector P/B
1.74
Sec. Div. Yield
73.7
Remus Pharmaceuticals Resistance and Support
Pivot 820
Resistance
First Resistance
825.5
Second Resistance
830.5
Third Resistance
836
Support
First Support
815
Second Support
809.5
Third Support
804.5
Remus Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Nov 09 2026 | 816 | 820.5 | 0.67% | 825 | 814.5 |
| Sun Nov 08 2026 | 810 | 815 | 1.82% | 830 | 800 |
| Fri Nov 06 2026 | 817 | 800.45 | -4.68% | 820 | 782 |
Remus Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-03 | Quarterly Results |
| 2026-05-20 | Audited Results |
| 2025-11-10 | Quarterly Results & Interim Dividend |
| 2025-05-17 | Audited Results |
| 2024-11-09 | Quarterly Results & Interim Dividend |
Remus Pharmaceuticals Management
| Name | Position |
|---|---|
| Deval Bakulkumar Patel | Company Secretary & Compliance Officer |
| Arpit Deepakkumar Shah | Managing Director |
Remus Pharmaceuticals Similar Stocks
Sejal Glass Ltd.
870.30
0.00 (0.00%)
Borosil Scientific Ltd.
110.09
0.00 (0.00%)
Elitecon International Ltd.
6.01
0.00 (0.00%)
TCC Concept Ltd.
40.39
0.00 (0.00%)
Orient Technologies Ltd.
202.00
0.00 (0.00%)
Antony Waste Handling Cell Ltd.
308.75
0.00 (0.00%)
Manoj Vaibhav Gems 'N' Jewellers Ltd.
179.17
0.00 (0.00%)
Krystal Integrated Services Ltd
615.35
0.00 (0.00%)
Hexa Tradex Ltd.
156.30
0.00 (0.00%)
Remus Pharmaceuticals FAQs
The Buying Price of Remus Pharmaceuticals share is 820.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Remus Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Remus Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Remus Pharmaceuticals shares is 26.14. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Remus Pharmaceuticals shares is 2.75. Useful to assess the stock's value relative to its book value.
To assess Remus Pharmaceuticals’s valuation compare Sector P/E, P/B which are 61.48 & 1.74 with sector averages, along with growth rates and financial metrics.
The Market Cap of Remus Pharmaceuticals is 966.88 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Remus Pharmaceuticals share price is 1039.00 & 580.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Remus Pharmaceuticals belongs to the Miscellaneous sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in REMUS
